EMA/PE/0000243891

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 99, Status: Authorised

EMA/PE/0000245064

Women's health

Regulatory perspectives on herbal medicinal / botanical drug product development: Joint FDA / EMA workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 September 2026, 10:00 (CEST) to 25 September 2026, 13:00 (CEST)

Human medicines European public assessment report (EPAR): Pritor, telmisartan, Date of authorisation: 11/12/1998, Revision: 31, Status: Withdrawn

Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 7, Status: Authorised

Meeting of the HMA-EMA group focused on AI with industry stakeholders - October 2026, Online, from 5 October 2026, 10:30 (CEST) to 5 October 2026, 12:00 (CEST)

EMA/PE/0000245149

EMA/PE/0000241632